Korfitz Bengt-Ingvar Ohlsson

Title: Korfitz Bengt-Ingvar Ohlsson: Innovator in Antidepressant Composition

Introduction

Korfitz Bengt-Ingvar Ohlsson is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressant compositions. His work has the potential to impact the treatment of mental health conditions.

Latest Patents

Ohlsson holds a patent for an antidepressant composition. This invention relates to novel solid compositions, such as tablets, pills, dispersible powders, granules, or capsules. The active ingredient in his composition is the compound 4'-chloro-2-{[3-(10,11-dihydro-5H-dibenz(b,f)-azepinyl-(5)-propyl]-methyla mino}-acetophenone hydrochloride, commonly referred to as lofepramine hydrochloride. This innovative approach aims to enhance the efficacy of antidepressant treatments.

Career Highlights

Ohlsson is associated with Aktiebolaget Leo, a company known for its focus on pharmaceutical advancements. His work at the company has allowed him to explore and develop new therapeutic solutions. With a patent portfolio that includes 1 patent, Ohlsson continues to contribute to the field of mental health.

Collaborations

Ohlsson collaborates with Edgar Eriksoo, a fellow professional in the industry. Their partnership exemplifies the importance of teamwork in driving innovation and advancing research in pharmaceuticals.

Conclusion

Korfitz Bengt-Ingvar Ohlsson is a dedicated inventor whose work in antidepressant compositions showcases his commitment to improving mental health treatments. His contributions are valuable to the pharmaceutical industry and have the potential to benefit many individuals.